|
133
|
421
|
6ngaA |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-2,6-difluorophenethyl)-4-methylpyridin-2-amine |
|
137
|
421
|
6ng4A |
Structure of human neuronal nitric oxide synthase r354a/g357d mutant heme domain in complex with (r)-6-(3-fluoro-5-(2-(pyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine |
|
165
|
564
|
6n1sA |
Toxoplasma gondii ts-dhfr in complex with selective inhibitor 29 |
|
144
|
564
|
6n1tA |
Toxoplasma gondii ts-dhfr in complex with selective inhibitor 3 |
|
167
|
472
|
6ma7A |
Human cyp3a4 bound to an inhibitor fluconazole |
|
172
|
472
|
6ma8A |
Human cyp3a4 bound to pmsf |
|
155
|
472
|
6ma6A |
Human cyp3a4 bound to an inhibitor metyrapone |
|
150
|
449
|
6c6pA |
Human squalene epoxidase (sqle, squalene monooxygenase) structure with fad and nb-598 |
|
150
|
451
|
6c6rA |
Human squalene epoxidase (sqle, squalene monooxygenase) structure with fad |
|
101
|
265
|
5qijA |
Crystal structure of murine 11b- hydroxysteroiddehydrogenase complexed with 2-(3-(1-(4- chlorophenyl)cyclopropyl)-[1,2,4]triazolo[4,3-a]pyridin-8- yl)propan-2-ol |
|
94
|
262
|
5qiiA |
Crystal structure of 11beta-hsd1 double mutant (l262r, f278e) complexed with 2-(3-(1-(4-chlorophenyl)cyclopropyl) -[1,2,4]triazolo[4,3-a]pyridin-8-yl)propan-2-ol |
|
107
|
354
|
6d4sA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 37 (vcc670597) |
|
173
|
463
|
6om8A |
Caenorhabditis elegans udp-glucose dehydrogenase in complex with udp-xylose |
|
106
|
354
|
6d4vA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 22 (vcc061422) |
|
106
|
355
|
6d4qA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 14 (vcc900455) |
|
104
|
354
|
6d4tA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 45 (vcc117054) |
|
149
|
470
|
6da8A |
Human cyp3a4 bound to an inhibitor |
|
162
|
470
|
6dacA |
Human cyp3a4 bound to an inhibitor |
|
163
|
470
|
6dalA |
Human cyp3a4 bound to an inhibitor |
|
149
|
470
|
6da3A |
Human cyp3a4 bound to an inhibitor |
|
110
|
355
|
6d4rA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 18 (vcc399134) |
|
172
|
608
|
6a2pA |
Crystal structure of quadruple mutant (n51i+c59r+s108n+i164l) plasmodium falciparum dhfr-ts complexed with bt3, nadph, and dump |
|
155
|
470
|
6daaA |
Human cyp3a4 bound to an inhibitor |
|
145
|
469
|
6dajA |
Human cyp3a4 bound to an inhibitor |
|
142
|
468
|
6dabA |
Human cyp3a4 bound to an inhibitor |
|
157
|
470
|
6da5A |
Human cyp3a4 bound to an inhibitor |
|
149
|
470
|
6dagA |
Human cyp3a4 bound to an inhibitor |
|
152
|
469
|
6da2A |
Human cyp3a4 bound to an inhibitor |
|
182
|
494
|
6dumA |
Aldh1a1 n121s in complex with 6-{[(3-fluorophenyl)methyl]sulfanyl}-2-(oxetan-3-yl)-5-phenyl-2,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-one (compound 13g) |
|
108
|
354
|
6d4uA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 27 (vcc663664) |
|
108
|
354
|
6d4wA |
M. thermoresistible guab2 delta-cbs in complex with inhibitor compound 35 (vcc620637) |
|
130
|
448
|
6aejA |
Crystal structure of human fto in complex with small-molecule inhibitors |
|
168
|
608
|
6a2oA |
Crystal structure of wild type plasmodium falciparum dhfr-ts complexed with bt3, nadph, and dump |
|
88
|
317
|
5islA |
Linked kdm5a jmj domain bound to the inhibitor c49 (2-{[(2-{[(e)-2-(dimethylamino)ethenyl](ethyl)amino}-2-oxoethyl)amino]methyl}pyridine-4-carboxylic acid) |
|
135
|
421
|
3tguB |
Cytochrome bc1 complex from chicken with pfvs-designed moa inhibitor bound |
|
76
|
241
|
3tguD |
Cytochrome bc1 complex from chicken with pfvs-designed moa inhibitor bound |
|
39
|
196
|
3tguE |
Cytochrome bc1 complex from chicken with pfvs-designed moa inhibitor bound |
|
188
|
492
|
6aljA |
Aldh1a2 liganded with nad and compound win18,446 |
|
132
|
418
|
5vupA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 7-(((3-(5-fluoropyridin-3-yl)propyl)amino)methyl)quinolin-2-amine |
|
127
|
418
|
5vuuA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 4-(2-(((2-amino-4-methylquinolin-7-yl)methyl)amino)ethyl)-2-methylbenzonitrile |
|
127
|
418
|
5vurA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 4-(2-(((2-aminoquinolin-7-yl)methyl)amino)ethyl)-2-methylbenzonitrile |
|
183
|
494
|
5l2oA |
Crystal structure of aldh1a1 in complex with buc22 |
|
182
|
494
|
5l13A |
Structure of aldh2 in complex with 2p3 |
|
184
|
494
|
5l2nA |
Structure of aldh1a1 in complex with buc25 |
|
137
|
463
|
6iq5A |
Crystal structure of cyp1b1 and inhibitor having azide group |
|
117
|
318
|
5jm5A |
Crystal structure of akr1c3 complexed with a pro-drug |
|
89
|
268
|
5jfoA |
Structure of the m.tuberculosis enoyl-reductase inha in complex with gsk625 |
|
139
|
362
|
5k9cA |
Crystal structure of human dihydroorotate dehydrogenase with ml390 |
|
88
|
317
|
5ivvA |
Linked kdm5a jmj domain bound to the inhibitor n12 [3-((1-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)amino)isonicotinic acid] |
|
91
|
317
|
5ivjA |
Linked kdm5a jmj domain bound to the inhibitor n11 [3-({1-[2-(4,4-difluoropiperidin-1-yl)ethyl]-5-fluoro-1h-indazol-3-yl}amino)pyridine-4-carboxylic acid] |
